> Rosetta Genomics has cut the price range for its IPO to $7.50 to $8.50 a share. Report
> An FDA advisory committee will examine safety and efficacy issues surrounding the vaccine Pentacel from Sanofi-Aventis. Report
> Molecular Insight Pharmaceuticals has inked a licensing deal to develop and sell Onalta, a radiotherapeutic candidate, from Novartis. No financial details were released. Release
> GPC Biotech has raised € 33.6 million in a private placement. Release
> Chutes & Ladders: John Dyer is moving from CMS to the FDA, where he will be the deputy commissioner for operations and the new COO. Report
And Finally... A new study says that learning can slow the development of brain lesions in Alzheimer's. Report